1. Sadhu, A., Upadhyay, P., Agrawal, A., Ilango, K., Karmakar, D., Singh, G. and Dubey, G. (2014). Management of Cognitive Determinants in Senile Dementia of Alzheimer’s Type: Therapeutic Potential of a Novel Polyherbal Drug Product. Clinical Drug Investigation, 34(12), pp.857-869.
  2. Benson, Sarah et al. “An Acute, Double-Blind, Placebo-Controlled Cross-Over Study Of 320 Mg And 640 Mg Doses Ofbacopa Monnieri(CDRI 08) On Multitasking Stress Reactivity And Mood.” Phytotherapy Research 28.4 (2013): 551-559.
  3. Kongkeaw, Chuenjid et al. “Meta-Analysis Of Randomized Controlled Trials On Cognitive Effects Of Bacopa Monnieri Extract.” Journal of Ethnopharmacology 151.1 (2014): 528-535.
  4. Pase, Matthew P. et al. “The Cognitive-Enhancing Effects Ofbacopa Monnieri: A Systematic Review Of Randomized, Controlled Human Clinical Trials.” The Journal of Alternative and Complementary Medicine 18.7 (2012): 647-652.
  5. Nathan, Pradeep J. et al. “Effects Of A Combined Extract Of Ginkgo Biloba And Bacopa Monniera On Cognitive Function In Healthy Humans.” Human Psychopharmacology: Clinical and Experimental 19.2 (2004): 91-96.
  6. Yang, Guoyan et al. “Huperzine A For Alzheimer’s Disease: A Systematic Review And Meta-Analysis Of Randomized Clinical Trials.” PLoS ONE 8.9 (2013): e74916.
  7. Zheng, W et al. “Huperzine A For Treatment Of Cognitive Impairment In Major Depressive Disorder: A Systematic Review Of Randomized Controlled Trials..” Shanghai Arch Psychiatry 28.2 (2016): 64-71.
  8. Laver, Kate et al. “Interventions To Delay Functional Decline In People With Dementia: A Systematic Review Of Systematic Reviews.” BMJ Open 6.4 (2016): e010767.
  9. Shao, ZQ. “Comparison Of The Efficacy Of Four Cholinesterase Inhibitors In Combination With Memantine For The Treatment Of Alzheimer’s Disease..” Int J Clin Exp Med 8.2 (2015): 2944-8. Print.
  10. Xing, SH et al. “Huperzine A In The Treatment Of Alzheimer’s Disease And Vascular Dementia: A Meta-Analysis..” Evid Based Complement Alternat Med 2014.363985 (2014): n. pag. Print.